Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 866 JPY 2.93%
Market Cap: 676.9B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 3 092.66 JPY. Compared to the current market price of 2 866 JPY, Rohto Pharmaceutical Co Ltd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 092.66 JPY
Undervaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
60
vs Industry
16
Median 3Y
2.9
Median 5Y
2.6
Industry
1
Forward
2
More Details
24
P/E
P/E
Price to Earnings
24
vs History
74
vs Industry
20
Median 3Y
26.2
Median 5Y
25.9
Industry
16.8
Forward
18.4
More Details
16.6
P/OCF
P/OCF
Price to OCF
16.6
vs History
96
vs Industry
14
Median 3Y
24
Median 5Y
20.9
Industry
11.9
More Details
11.7
P/FCFE
P/FCFE
Price to FCFE
11.7
vs History
98
vs Industry
15
Median 3Y
52.6
Median 5Y
32.1
Industry
17.6
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
84
vs Industry
17
Median 3Y
3.2
Median 5Y
2.9
Industry
1.6
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
57
vs Industry
19
Median 3Y
2.7
Median 5Y
2.3
Industry
1.2
Forward
1.9
More Details
3.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.8
vs History
57
vs Industry
36
Median 3Y
4.6
Median 5Y
4
Industry
3.8
More Details
13.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.3
vs History
52
vs Industry
22
Median 3Y
15.4
Median 5Y
12.8
Industry
10.3
Forward
10.7
More Details
16.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.5
vs History
50
vs Industry
22
Median 3Y
18.7
Median 5Y
16
Industry
12.9
More Details
15.5
EV/OCF
EV/OCF
Enterprise Value to OCF
15.5
vs History
85
vs Industry
17
Median 3Y
21.6
Median 5Y
18.7
Industry
12.1
More Details
20.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.7
vs History
93
vs Industry
16
Median 3Y
32.2
Median 5Y
29.6
Industry
15.3
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
93
vs Industry
16
Median 3Y
2.9
Median 5Y
2.4
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Rohto Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
653.8B JPY 2.3 24 13.3 16.5
JP
Fancl Corp
TSE:4921
336.7B JPY 3.1 47.6 19.9 26.9
FR
L'Oreal SA
PAR:OR
182B EUR 4.2 28 18.6 22.2
UK
Unilever PLC
LSE:ULVR
113.9B GBP 2.3 20.7 177.4 203.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 53.2 36.5 39.8
UK
HALEON PLC
LSE:HLN
34.8B GBP 3.1 28.8 17.1 19.6
DE
Beiersdorf AG
XETRA:BEI
27.8B EUR 2.9 37.6 16 22.9
US
Estee Lauder Companies Inc
NYSE:EL
26.8B USD 1.7 132.2 13.1 19.9
JP
Kao Corp
TSE:4452
3T JPY 1.9 36.4 14.4 26.1
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.8 -297.8 35.4 37.8
IN
Dabur India Ltd
NSE:DABUR
903.8B INR 7.3 50.5 38.3 46.7
P/E Multiple
Earnings Growth P/E to Growth
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
Average P/E: 45.9
24
43%
0.6
JP
F
Fancl Corp
TSE:4921
47.6
50%
1
FR
L'Oreal SA
PAR:OR
28
30%
0.9
UK
Unilever PLC
LSE:ULVR
20.7
25%
0.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
53.2
32%
1.6
UK
HALEON PLC
LSE:HLN
28.8
-7%
N/A
DE
Beiersdorf AG
XETRA:BEI
37.6
61%
0.6
US
Estee Lauder Companies Inc
NYSE:EL
132.2
245%
0.5
JP
Kao Corp
TSE:4452
36.4
205%
0.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -297.8 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
50.5
39%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
Average EV/EBITDA: 36.4
13.3
44%
0.3
JP
F
Fancl Corp
TSE:4921
19.9
37%
0.5
FR
L'Oreal SA
PAR:OR
18.6
28%
0.7
UK
Unilever PLC
LSE:ULVR
177.4
20%
8.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.5
29%
1.2
UK
HALEON PLC
LSE:HLN
17.1
13%
1.3
DE
Beiersdorf AG
XETRA:BEI
16
11%
1.4
US
Estee Lauder Companies Inc
NYSE:EL
13.1
26%
0.5
JP
Kao Corp
TSE:4452
14.4
55%
0.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
35.4
41%
0.9
IN
Dabur India Ltd
NSE:DABUR
38.3
35%
1.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
Average EV/EBIT: 43.9
16.5
N/A N/A
JP
F
Fancl Corp
TSE:4921
26.9
N/A N/A
FR
L'Oreal SA
PAR:OR
22.2
34%
0.7
UK
Unilever PLC
LSE:ULVR
203.9
22%
9.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.8
31%
1.3
UK
HALEON PLC
LSE:HLN
19.6
13%
1.5
DE
Beiersdorf AG
XETRA:BEI
22.9
21%
1.1
US
Estee Lauder Companies Inc
NYSE:EL
19.9
35%
0.6
JP
Kao Corp
TSE:4452
26.1
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
37.8
44%
0.9
IN
Dabur India Ltd
NSE:DABUR
46.7
37%
1.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.